NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND

NEUROMYELITIS OPTICA IN SOUTH WALES AND THE SOUTH WEST OF ENGLAND

Dades bibliogràfiques
Autors principals:	Luppe, S, Harding, K, Cossburn, M, Ingram, G, Palace, J, Kitley, J, Leite, M, Jacob, A, Robertson, N
Format:	Conference item
Publicat:	2012

Ítems similars

Seasonal pattern of variation in neuromyelitis optica relapses
per: Elsone, L, et al.
Publicat: (2012)

Use of mitoxantrone in neuromyelitis optica.
per: Kitley, J, et al.
Publicat: (2011)

Is azathioprine effective in highly-active neuromyelitis optica? A multicentre study from the United Kingdom
per: Elsone, L, et al.
Publicat: (2013)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials.
per: Kitley, J, et al.
Publicat: (2014)

Time to next relapse as a primary endpoint in neuromyelitis optica clinical trials
per: Kitley, J, et al.
Publicat: (2014)

METHOTREXATE MAY BE AN ALTERNATIVE TO AZATHIOPRINE IN NEUROMYELITIS OPTICA WITH AQUAPORIN-4 ANTIBODIES
per: Kitley, J, et al.
Publicat: (2012)

A practical guide to the treatment of neuromyelitis optica.
per: Palace, J, et al.
Publicat: (2012)

LONGITUDINALLY EXTENSIVE TRANSVERSE MYELITIS: A VARIETY OF CAUSES SEEN WITHIN THE NATIONAL NEUROMYELITIS OPTICA SERVICE
per: Kitley, J, et al.
Publicat: (2012)

Long term efficacy, adherence and reasons for discontinuation in 103 cases of neuromyelitis optica treated with azathioprine: a multicentre study from the United Kingdom
per: Elsone, L, et al.
Publicat: (2013)

TREATMENT OF NEUROMYELITIS OPTICA WITH AZATHIOPRINE
per: Elsone, L, et al.
Publicat: (2012)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
per: Jacob, A, et al.
Publicat: (2012)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
per: Collongues, N, et al.
Publicat: (2013)

A clinical/immunological neuromyelitis optica association study
per: Kitley, J, et al.
Publicat: (2014)

NEUROMYELITIS OPTICA SPECTRUM DISORDER AND CMV RETINITIS: A CASE REPORT
per: George, J, et al.
Publicat: (2012)

Pain in neuromyelitis optica spectrum disease: a cross-sectional study in an English cohort
per: Leonard, H, et al.
Publicat: (2012)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies
per: Kitley, J, et al.
Publicat: (2013)

Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
per: Kitley, J, et al.
Publicat: (2013)

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
per: Kitley, J, et al.
Publicat: (2012)

The borderland of neuromyelitis optica.
per: Matthews, L, et al.
Publicat: (2009)

Aquaporin-4 Antibody Isoform Binding Specificity Does Not Explain Clinical Variations in Neuromyelitis Optica
per: Kitley, J, et al.
Publicat: (2013)

Alternative antigen targets in aquaporin-4 antibodynegative neuromyelitis optica spectrum disorders
per: Kitley, J, et al.
Publicat: (2013)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
per: Waters, P, et al.
Publicat: (2015)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
per: Absoud, M, et al.
Publicat: (2014)

Influence of pregnancy on neuromyelitis optica spectrum disorder.
per: Kim, W, et al.
Publicat: (2012)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
per: Kitley, J, et al.
Publicat: (2014)

The impact of neuromyelitis optica spectrum disorder on pregnancy outcome
per: Nour, M, et al.
Publicat: (2014)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
per: Kitley, J, et al.
Publicat: (2011)

Long-term efficacy, tolerability and retention rate of azathioprine in 103 aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder patients: a multicentre retrospective observational study from the UK.
per: Elsone, L, et al.
Publicat: (2014)

Neuromyelitis optica spectrum disorder and multiple sclerosis can be distinguished on the basis of MRI brain lesion characteristics
per: Matthews, L, et al.
Publicat: (2012)

Magnetic resonance imaging in neuromyelitis optica.
per: Tackley, G, et al.
Publicat: (2014)

Neuromyelitis optica
per: Jacob Anu, et al.
Publicat: (2007-01-01)

Treatment of Neuromyelitis Optica: Review and Recommendations.
per: Kimbrough, D, et al.
Publicat: (2012)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
per: Kitley, J, et al.
Publicat: (2014)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
per: Kitley, J, et al.
Publicat: (2014)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
per: Kitley, J, et al.
Publicat: (2012)

The evolving clinical spectrum of neuromyelitis optica
per: Viegas, S, et al.
Publicat: (2008)

Treatment of neuromyelitis optica: Review and recommendations
per: Kimbrough, D, et al.
Publicat: (2012)

Symptomatic, radiological and pathological involvement of the hypothalamus in neuromyelitis optica.
per: Viegas, S, et al.
Publicat: (2009)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: is MRI obsolete?
per: Downer, J, et al.
Publicat: (2012)

Diagnosis of neuromyelitis optica (NMO) spectrum disorders: Is MRI obsolete?
per: Downer, J, et al.
Publicat: (2012)